DV Wordmark-Sm

Janssen COVID-19 Vaccine

FDA currently approves Janssen Covid-19 vaccine for emergency use authorization as a single primary vaccination dose for individuals 18 years of age and older and as a single booster dose for individuals 18 years of age and older at least two months after first dose.

Contraindications
  • Allergy or Hypersensitivity
  • Thrombosis with Thrombocytopenia
Precautions and Warnings
  • Allergy or Hypersensitivity
  • Thrombosis with Thrombocytopenia
  • Immune thrombocytopenia
  • Guillain-Barr√© Syndrome
  • Altered immunocompetence
  • Syncopy
  • Limitation of vaccine effectiveness.

Coronavirus Vaccines and Therapeutics